Vistagen Therapeutics, Inc. (VTGN)
0.1706
0.00 (0.00%)
USD |
NASDAQ |
Oct 29, 16:00
0.1706
0.00 (0.00%)
After-Hours: 20:00
Vistagen Therapeutics Market Cap : 7.571M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 7.545M |
| October 27, 2026 | 7.722M |
| October 26, 2026 | 7.714M |
| October 23, 2026 | 7.975M |
| October 22, 2026 | 8.299M |
| October 21, 2026 | 8.592M |
| October 20, 2026 | 8.779M |
| October 19, 2026 | 9.014M |
| October 16, 2026 | 8.876M |
| October 15, 2026 | 9.453M |
| October 14, 2026 | 9.169M |
| October 13, 2026 | 9.533M |
| October 12, 2026 | 10.06M |
| October 09, 2026 | 10.48M |
| October 08, 2026 | 10.93M |
| October 07, 2026 | 10.97M |
| October 06, 2026 | 11.12M |
| October 05, 2026 | 11.68M |
| October 02, 2026 | 12.47M |
| October 01, 2026 | 12.54M |
| September 30, 2026 | 13.66M |
| September 29, 2026 | 13.23M |
| September 28, 2026 | 13.18M |
| September 25, 2026 | 12.12M |
| September 24, 2026 | 13.09M |
| Date | Value |
|---|---|
| September 23, 2026 | 16.35M |
| September 22, 2026 | 11.16M |
| September 21, 2026 | 10.34M |
| September 18, 2026 | 10.65M |
| September 17, 2026 | 10.37M |
| September 16, 2026 | 10.23M |
| September 15, 2026 | 10.48M |
| September 14, 2026 | 10.79M |
| September 11, 2026 | 10.52M |
| September 10, 2026 | 10.61M |
| September 09, 2026 | 10.45M |
| September 08, 2026 | 10.80M |
| September 04, 2026 | 10.78M |
| September 03, 2026 | 10.93M |
| September 02, 2026 | 10.92M |
| September 01, 2026 | 10.80M |
| August 31, 2026 | 11.32M |
| August 28, 2026 | 11.22M |
| August 27, 2026 | 11.41M |
| August 26, 2026 | 11.54M |
| August 25, 2026 | 11.02M |
| August 24, 2026 | 10.82M |
| August 21, 2026 | 10.83M |
| August 20, 2026 | 10.70M |
| August 19, 2026 | 10.83M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Onconetix, Inc. | 2.195M |
| ACADIA Pharmaceuticals, Inc. | 3.573B |
| Alnylam Pharmaceuticals, Inc. | 23.26B |
| Anika Therapeutics, Inc. | 291.35M |
| Savara, Inc. | 1.018B |
Market Cap Related Metrics
| PS Ratio | 2.737 |
| Price to Book Value | 0.3093 |
| Price | 0.1706 |
| Earnings Yield | -999.2% |